Efficacy and safety of a Unani compound drug– Habb-e-Asgand in Waja‘al-Mafāsil (Rheumatoid Arthritis) cases- A preliminary study

Verma, Ramesh Pal Singh; Khan, Parvez Anwar; Ayub, S; Afza, S; Akhtar, Jamal; Ahmad, Shama; Khan, Asadullah

doi:10.56042/ijtk.v20i1.27232

Cited by 4 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Currently available NSAID s and DMARD s reduce inflammation but they are having side effects and affect the organs like liver. These drugs develop tolerance and therefore the dose is increased gradually (32). Hence the drug Amirdha Gandhi Kukkil Vallathy will be a safe and effective Siddha medicine to manage the symptoms in earlier phase of Uthira vatha suronitham (Rheumatoid arthritis).…”

Section: Table 1-assessment Of Casesmentioning

confidence: 99%

Management of Uthiravathasuronitham (Rheumatoid arthritis) by Siddha traditional formulation Amirdha Gandhi Kukkil Vallathy – A case series

L¹,

S²,

Cotsoglou³

et al. 2023

IJAM

View full text Add to dashboard Cite

Aim and Objectives: Rheumatoid arthritis is an auto immune disease and its signs and symptoms are correlated with Uthira vatha Suronitham (UVS) in Siddha. Here we discussed a case series of Rheumatoid arthritis managed by a novel, classical Siddha formulation Amirdha Gandhi Kukkil Vallathy (AGKV). Methods: Three cases were diagnosed as Rheumatoid arthritis (RA) based on ACR/EULAR 2010 criteria, along with symptoms of UVS as per Siddha literature. All the three cases were treated with Siddha medicine AGKV 2 gm bid for 48 days in the General out patients department, Siddha Central Research Institute. Observations: The assessment was made by the signs and symptoms and serological parameters like C-Reactive protein (CRP), Erythrocyte Sedimentation Rate (ESR), Haemoglobin (Hb), Rheumatoid Arthritis factor (RA factor). Results: The RA Factor was reduced in all three patients from 60 to 13.9, from 133 to 106, from 60.7 IU/ml to 35.6 IU/ml ; CRP reduced in case 1 from 135.8 to 34.3, case 3 from 18.9 to 5.6, reduction in RAPS score and clinical symptoms were noticed in all three cases and were followed for 1 year and managed with diet advice. This case series highlights that RA can be successfully managed with Siddha herbo mineral preparation AGKV within a minimum period of 48 days. Hence in a long duration of treatment, it will certainly give good results to reduce the burden of RA patients.

show abstract

Section: Table 1-assessment Of Casesmentioning

confidence: 99%